Janux Therapeutics, Inc. (JANX) Operating cash flow 2020–2025
Janux Therapeutics, Inc. (JANX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$82.2MFY2025 · since FY2020: -$4.4M → -$82.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$82.2M | -87.7% |
| FY2024 | -$43.8M | +13.4% |
| FY2023 | -$50.6M | -17.8% |
| FY2022 | -$42.9M | -152.8% |
| FY2021 | -$17.0M | -288.6% |
| FY2020 | -$4.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice